Dare Bioscience Inc (NAS:DARE)
$ 3.1879 -0.0121 (-0.38%) Market Cap: 27.84 Mil Enterprise Value: 18.01 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q1 2024 Dare Bioscience Inc Earnings Call Transcript

May 14, 2024 / 08:30PM GMT
Release Date Price: $3.78 (-0.06%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's First Quarter Financial Results and to provide the General Business Update. This call is being recorded. My name is Alex and I will be your operator for today.

With us today from Daré are Sabrina Martucci Johnson, President and Chief Executive Officer; and MarDee Haring-Layton, Chief Accounting Officer. Ms. Johnson, please proceed.

Sabrina Martucci Johnson Dare Bioscience
Inc. - President & CEO

Thank you. Good afternoon and welcome to the Daré Bioscience Financial Results and Business Update Call for the quarter ended March 31, 2024. Today, we'll review our first quarter results and discuss developments and expectations from our pipeline and portfolio.

I would like to remind you that today's discussion will include forward-looking statements within the meaning of the Federal Securities Laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot